Time to Progression of AFP (TPA) as a Predictor of Survival in Hepatocellular Carcinoma Treated with Sorafenib (SOR) (Articles)
Maria Varela, Olegario Castaño-Fernández, Marcelo Garrido, Lorena Blanco-García, Pablo Martínez-Camblor, Alicia Mesa-Álvarez, Carmen Navascués, Valle Cadahía-Rodrigo, Rafael Menéndez de Llano, Ramon Pérez-Álvarez, Maria Luisa González-Diéguez, Manuel Rodríguez
Journal of Cancer Therapy
Vol.5 No.14,December 3, 2014
DOI:
10.4236/jct.2014.514133
3,593 Downloads 4,003 Views Citations
This article belongs to the Special Issue on
Advances in Hepatocellular Carcinoma Research